nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentazocine—EBP—Sirolimus—Pimecrolimus—atopic dermatitis	0.00628	0.238	CbGdCrCtD
Pentazocine—EBP—Temsirolimus—Pimecrolimus—atopic dermatitis	0.00628	0.238	CbGdCrCtD
Pentazocine—EBP—Sirolimus—Tacrolimus—atopic dermatitis	0.00628	0.238	CbGdCrCtD
Pentazocine—EBP—Temsirolimus—Tacrolimus—atopic dermatitis	0.00628	0.238	CbGdCrCtD
Pentazocine—Vomiting—Diphenhydramine—atopic dermatitis	0.00192	0.00259	CcSEcCtD
Pentazocine—Feeling abnormal—Loratadine—atopic dermatitis	0.00192	0.00258	CcSEcCtD
Pentazocine—Dysgeusia—Tacrolimus—atopic dermatitis	0.00191	0.00257	CcSEcCtD
Pentazocine—Anorexia—Mometasone—atopic dermatitis	0.00191	0.00256	CcSEcCtD
Pentazocine—Dermatitis—Dimenhydrinate—atopic dermatitis	0.0019	0.00256	CcSEcCtD
Pentazocine—Dermatitis—Diphenhydramine—atopic dermatitis	0.0019	0.00256	CcSEcCtD
Pentazocine—Headache—Diphenhydramine—atopic dermatitis	0.00189	0.00255	CcSEcCtD
Pentazocine—Headache—Dimenhydrinate—atopic dermatitis	0.00189	0.00255	CcSEcCtD
Pentazocine—Muscle spasms—Tacrolimus—atopic dermatitis	0.00187	0.00252	CcSEcCtD
Pentazocine—Vomiting—Pimecrolimus—atopic dermatitis	0.00186	0.0025	CcSEcCtD
Pentazocine—Dermatitis—Pimecrolimus—atopic dermatitis	0.00184	0.00248	CcSEcCtD
Pentazocine—Vision blurred—Tacrolimus—atopic dermatitis	0.00184	0.00247	CcSEcCtD
Pentazocine—Headache—Pimecrolimus—atopic dermatitis	0.00183	0.00246	CcSEcCtD
Pentazocine—Tremor—Tacrolimus—atopic dermatitis	0.00183	0.00246	CcSEcCtD
Pentazocine—Visual disturbance—Betamethasone—atopic dermatitis	0.00182	0.00245	CcSEcCtD
Pentazocine—Visual disturbance—Dexamethasone—atopic dermatitis	0.00182	0.00245	CcSEcCtD
Pentazocine—Irritability—Methylprednisolone—atopic dermatitis	0.00181	0.00244	CcSEcCtD
Pentazocine—Nausea—Dimenhydrinate—atopic dermatitis	0.0018	0.00242	CcSEcCtD
Pentazocine—Nausea—Diphenhydramine—atopic dermatitis	0.0018	0.00242	CcSEcCtD
Pentazocine—Paraesthesia—Mometasone—atopic dermatitis	0.00179	0.00241	CcSEcCtD
Pentazocine—Agitation—Tacrolimus—atopic dermatitis	0.00179	0.00241	CcSEcCtD
Pentazocine—Dyspnoea—Mometasone—atopic dermatitis	0.00178	0.0024	CcSEcCtD
Pentazocine—Euphoric mood—Prednisone—atopic dermatitis	0.00178	0.00239	CcSEcCtD
Pentazocine—Vertigo—Tacrolimus—atopic dermatitis	0.00175	0.00236	CcSEcCtD
Pentazocine—Syncope—Tacrolimus—atopic dermatitis	0.00175	0.00235	CcSEcCtD
Pentazocine—Sweating increased—Prednisolone—atopic dermatitis	0.00174	0.00234	CcSEcCtD
Pentazocine—Decreased appetite—Mometasone—atopic dermatitis	0.00174	0.00234	CcSEcCtD
Pentazocine—Nausea—Pimecrolimus—atopic dermatitis	0.00174	0.00234	CcSEcCtD
Pentazocine—Loss of consciousness—Tacrolimus—atopic dermatitis	0.00171	0.0023	CcSEcCtD
Pentazocine—Sweating increased—Hydrocortisone—atopic dermatitis	0.0017	0.00229	CcSEcCtD
Pentazocine—Hypertension—Tacrolimus—atopic dermatitis	0.00168	0.00226	CcSEcCtD
Pentazocine—Asthenia—Loratadine—atopic dermatitis	0.00167	0.00225	CcSEcCtD
Pentazocine—Irritability—Betamethasone—atopic dermatitis	0.00165	0.00221	CcSEcCtD
Pentazocine—Irritability—Dexamethasone—atopic dermatitis	0.00165	0.00221	CcSEcCtD
Pentazocine—Dry mouth—Tacrolimus—atopic dermatitis	0.00162	0.00218	CcSEcCtD
Pentazocine—Confusional state—Tacrolimus—atopic dermatitis	0.0016	0.00216	CcSEcCtD
Pentazocine—Sweating increased—Triamcinolone—atopic dermatitis	0.0016	0.00215	CcSEcCtD
Pentazocine—Sweating increased—Methylprednisolone—atopic dermatitis	0.0016	0.00215	CcSEcCtD
Pentazocine—Diarrhoea—Loratadine—atopic dermatitis	0.00159	0.00214	CcSEcCtD
Pentazocine—Anaphylactic shock—Tacrolimus—atopic dermatitis	0.00159	0.00214	CcSEcCtD
Pentazocine—Shock—Tacrolimus—atopic dermatitis	0.00156	0.00211	CcSEcCtD
Pentazocine—Tachycardia—Tacrolimus—atopic dermatitis	0.00155	0.00209	CcSEcCtD
Pentazocine—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.00154	0.00207	CcSEcCtD
Pentazocine—Dizziness—Loratadine—atopic dermatitis	0.00154	0.00207	CcSEcCtD
Pentazocine—Hyperhidrosis—Tacrolimus—atopic dermatitis	0.00154	0.00207	CcSEcCtD
Pentazocine—Anorexia—Tacrolimus—atopic dermatitis	0.00152	0.00204	CcSEcCtD
Pentazocine—Hypotension—Tacrolimus—atopic dermatitis	0.00149	0.002	CcSEcCtD
Pentazocine—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.00148	0.00199	CcSEcCtD
Pentazocine—Vomiting—Loratadine—atopic dermatitis	0.00148	0.00199	CcSEcCtD
Pentazocine—Dermatitis—Loratadine—atopic dermatitis	0.00147	0.00197	CcSEcCtD
Pentazocine—Headache—Loratadine—atopic dermatitis	0.00146	0.00196	CcSEcCtD
Pentazocine—Sweating increased—Betamethasone—atopic dermatitis	0.00145	0.00195	CcSEcCtD
Pentazocine—Sweating increased—Dexamethasone—atopic dermatitis	0.00145	0.00195	CcSEcCtD
Pentazocine—Face oedema—Prednisone—atopic dermatitis	0.00145	0.00195	CcSEcCtD
Pentazocine—Insomnia—Tacrolimus—atopic dermatitis	0.00144	0.00194	CcSEcCtD
Pentazocine—Asthenia—Mometasone—atopic dermatitis	0.00143	0.00193	CcSEcCtD
Pentazocine—Irritability—Prednisone—atopic dermatitis	0.00143	0.00193	CcSEcCtD
Pentazocine—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.00143	0.00193	CcSEcCtD
Pentazocine—Paraesthesia—Tacrolimus—atopic dermatitis	0.00143	0.00192	CcSEcCtD
Pentazocine—Dyspnoea—Tacrolimus—atopic dermatitis	0.00142	0.00191	CcSEcCtD
Pentazocine—Somnolence—Tacrolimus—atopic dermatitis	0.00141	0.0019	CcSEcCtD
Pentazocine—Pruritus—Mometasone—atopic dermatitis	0.00141	0.0019	CcSEcCtD
Pentazocine—Sweating—Methylprednisolone—atopic dermatitis	0.0014	0.00189	CcSEcCtD
Pentazocine—Hallucination—Hydrocortisone—atopic dermatitis	0.00139	0.00187	CcSEcCtD
Pentazocine—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.00138	0.00186	CcSEcCtD
Pentazocine—Nausea—Loratadine—atopic dermatitis	0.00138	0.00186	CcSEcCtD
Pentazocine—Decreased appetite—Tacrolimus—atopic dermatitis	0.00138	0.00186	CcSEcCtD
Pentazocine—Visual impairment—Prednisolone—atopic dermatitis	0.00138	0.00185	CcSEcCtD
Pentazocine—Diarrhoea—Mometasone—atopic dermatitis	0.00137	0.00184	CcSEcCtD
Pentazocine—Constipation—Tacrolimus—atopic dermatitis	0.00136	0.00183	CcSEcCtD
Pentazocine—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.00133	0.00179	CcSEcCtD
Pentazocine—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.00132	0.00177	CcSEcCtD
Pentazocine—Headache—Fluocinolone Acetonide—atopic dermatitis	0.00131	0.00176	CcSEcCtD
Pentazocine—Feeling abnormal—Tacrolimus—atopic dermatitis	0.00131	0.00176	CcSEcCtD
Pentazocine—Hallucination—Methylprednisolone—atopic dermatitis	0.00131	0.00176	CcSEcCtD
Pentazocine—Vomiting—Mometasone—atopic dermatitis	0.00127	0.00171	CcSEcCtD
Pentazocine—SIGMAR1—Levonorgestrel—Hydrocortisone—atopic dermatitis	0.00127	0.048	CbGdCrCtD
Pentazocine—Sweating increased—Prednisone—atopic dermatitis	0.00126	0.0017	CcSEcCtD
Pentazocine—Visual impairment—Methylprednisolone—atopic dermatitis	0.00126	0.0017	CcSEcCtD
Pentazocine—Dermatitis—Mometasone—atopic dermatitis	0.00126	0.00169	CcSEcCtD
Pentazocine—Headache—Mometasone—atopic dermatitis	0.00125	0.00168	CcSEcCtD
Pentazocine—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.00124	0.00167	CcSEcCtD
Pentazocine—Hallucination—Betamethasone—atopic dermatitis	0.00119	0.0016	CcSEcCtD
Pentazocine—Hallucination—Dexamethasone—atopic dermatitis	0.00119	0.0016	CcSEcCtD
Pentazocine—Nausea—Mometasone—atopic dermatitis	0.00119	0.0016	CcSEcCtD
Pentazocine—Vision blurred—Prednisolone—atopic dermatitis	0.00117	0.00158	CcSEcCtD
Pentazocine—Hypersensitivity—Tacrolimus—atopic dermatitis	0.00117	0.00158	CcSEcCtD
Pentazocine—Visual impairment—Betamethasone—atopic dermatitis	0.00115	0.00155	CcSEcCtD
Pentazocine—Visual impairment—Dexamethasone—atopic dermatitis	0.00115	0.00155	CcSEcCtD
Pentazocine—Asthenia—Tacrolimus—atopic dermatitis	0.00114	0.00154	CcSEcCtD
Pentazocine—Pruritus—Tacrolimus—atopic dermatitis	0.00113	0.00151	CcSEcCtD
Pentazocine—OPRK1—G alpha (i) signalling events—CCR3—atopic dermatitis	0.00112	0.00488	CbGpPWpGaD
Pentazocine—Dysgeusia—Triamcinolone—atopic dermatitis	0.00112	0.00151	CcSEcCtD
Pentazocine—OPRM1—TCR Signaling Pathway—CCR5—atopic dermatitis	0.00112	0.00487	CbGpPWpGaD
Pentazocine—OPRD1—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.00112	0.00486	CbGpPWpGaD
Pentazocine—Vertigo—Prednisolone—atopic dermatitis	0.00112	0.0015	CcSEcCtD
Pentazocine—EBP—Metabolism—ADSL—atopic dermatitis	0.00112	0.00485	CbGpPWpGaD
Pentazocine—Syncope—Prednisolone—atopic dermatitis	0.00112	0.0015	CcSEcCtD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.0011	0.00476	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CCL22—atopic dermatitis	0.00109	0.00475	CbGpPWpGaD
Pentazocine—Loss of consciousness—Prednisolone—atopic dermatitis	0.00109	0.00147	CcSEcCtD
Pentazocine—Vertigo—Hydrocortisone—atopic dermatitis	0.00109	0.00147	CcSEcCtD
Pentazocine—Syncope—Hydrocortisone—atopic dermatitis	0.00109	0.00147	CcSEcCtD
Pentazocine—Diarrhoea—Tacrolimus—atopic dermatitis	0.00109	0.00146	CcSEcCtD
Pentazocine—Hypertension—Prednisolone—atopic dermatitis	0.00107	0.00145	CcSEcCtD
Pentazocine—OPRD1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.00107	0.00466	CbGpPWpGaD
Pentazocine—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.00107	0.00144	CcSEcCtD
Pentazocine—Dizziness—Tacrolimus—atopic dermatitis	0.00105	0.00142	CcSEcCtD
Pentazocine—Hypertension—Hydrocortisone—atopic dermatitis	0.00105	0.00141	CcSEcCtD
Pentazocine—OPRK1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00104	0.00453	CbGpPWpGaD
Pentazocine—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00104	0.00451	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—CCL17—atopic dermatitis	0.00104	0.00449	CbGpPWpGaD
Pentazocine—Hallucination—Prednisone—atopic dermatitis	0.00103	0.00139	CcSEcCtD
Pentazocine—Vertigo—Triamcinolone—atopic dermatitis	0.00103	0.00138	CcSEcCtD
Pentazocine—Syncope—Triamcinolone—atopic dermatitis	0.00103	0.00138	CcSEcCtD
Pentazocine—Vertigo—Methylprednisolone—atopic dermatitis	0.00103	0.00138	CcSEcCtD
Pentazocine—Syncope—Methylprednisolone—atopic dermatitis	0.00102	0.00138	CcSEcCtD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00102	0.00442	CbGpPWpGaD
Pentazocine—Anaphylactic shock—Prednisolone—atopic dermatitis	0.00102	0.00137	CcSEcCtD
Pentazocine—Vomiting—Tacrolimus—atopic dermatitis	0.00101	0.00136	CcSEcCtD
Pentazocine—Loss of consciousness—Triamcinolone—atopic dermatitis	0.00101	0.00135	CcSEcCtD
Pentazocine—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.001	0.00135	CcSEcCtD
Pentazocine—OPRM1—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.001	0.00436	CbGpPWpGaD
Pentazocine—OPRM1—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.001	0.00436	CbGpPWpGaD
Pentazocine—Dermatitis—Tacrolimus—atopic dermatitis	0.001	0.00135	CcSEcCtD
Pentazocine—Shock—Prednisolone—atopic dermatitis	0.001	0.00134	CcSEcCtD
Pentazocine—Headache—Tacrolimus—atopic dermatitis	0.000996	0.00134	CcSEcCtD
Pentazocine—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000992	0.00133	CcSEcCtD
Pentazocine—Tachycardia—Prednisolone—atopic dermatitis	0.000992	0.00133	CcSEcCtD
Pentazocine—Hypertension—Triamcinolone—atopic dermatitis	0.000988	0.00133	CcSEcCtD
Pentazocine—Hypertension—Methylprednisolone—atopic dermatitis	0.000986	0.00133	CcSEcCtD
Pentazocine—OPRM1—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.000984	0.00427	CbGpPWpGaD
Pentazocine—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000982	0.00132	CcSEcCtD
Pentazocine—OPRK1—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.000982	0.00426	CbGpPWpGaD
Pentazocine—Shock—Hydrocortisone—atopic dermatitis	0.000976	0.00131	CcSEcCtD
Pentazocine—OPRM1—GPCR ligand binding—CCL27—atopic dermatitis	0.000975	0.00424	CbGpPWpGaD
Pentazocine—Tachycardia—Hydrocortisone—atopic dermatitis	0.000968	0.0013	CcSEcCtD
Pentazocine—Flushing—Prednisone—atopic dermatitis	0.000964	0.0013	CcSEcCtD
Pentazocine—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000959	0.00129	CcSEcCtD
Pentazocine—Dry mouth—Triamcinolone—atopic dermatitis	0.000953	0.00128	CcSEcCtD
Pentazocine—OPRD1—GPCR ligand binding—CCL11—atopic dermatitis	0.000951	0.00413	CbGpPWpGaD
Pentazocine—OPRM1—TCR Signaling Pathway—NFKBIA—atopic dermatitis	0.00095	0.00413	CbGpPWpGaD
Pentazocine—OPRM1—G alpha (i) signalling events—CCR3—atopic dermatitis	0.000949	0.00412	CbGpPWpGaD
Pentazocine—Anorexia—Hydrocortisone—atopic dermatitis	0.000946	0.00127	CcSEcCtD
Pentazocine—Nausea—Tacrolimus—atopic dermatitis	0.000945	0.00127	CcSEcCtD
Pentazocine—OPRK1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000941	0.00408	CbGpPWpGaD
Pentazocine—Confusional state—Methylprednisolone—atopic dermatitis	0.00094	0.00126	CcSEcCtD
Pentazocine—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000934	0.00126	CcSEcCtD
Pentazocine—Vertigo—Betamethasone—atopic dermatitis	0.000933	0.00126	CcSEcCtD
Pentazocine—Vertigo—Dexamethasone—atopic dermatitis	0.000933	0.00126	CcSEcCtD
Pentazocine—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000932	0.00125	CcSEcCtD
Pentazocine—Syncope—Dexamethasone—atopic dermatitis	0.000932	0.00125	CcSEcCtD
Pentazocine—Syncope—Betamethasone—atopic dermatitis	0.000932	0.00125	CcSEcCtD
Pentazocine—Hypotension—Hydrocortisone—atopic dermatitis	0.000927	0.00125	CcSEcCtD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000926	0.00402	CbGpPWpGaD
Pentazocine—OPRD1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000924	0.00401	CbGpPWpGaD
Pentazocine—Shock—Triamcinolone—atopic dermatitis	0.000919	0.00124	CcSEcCtD
Pentazocine—Insomnia—Prednisolone—atopic dermatitis	0.000919	0.00124	CcSEcCtD
Pentazocine—Shock—Methylprednisolone—atopic dermatitis	0.000917	0.00123	CcSEcCtD
Pentazocine—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000913	0.00123	CcSEcCtD
Pentazocine—Loss of consciousness—Betamethasone—atopic dermatitis	0.000913	0.00123	CcSEcCtD
Pentazocine—Paraesthesia—Prednisolone—atopic dermatitis	0.000912	0.00123	CcSEcCtD
Pentazocine—Tachycardia—Triamcinolone—atopic dermatitis	0.000912	0.00123	CcSEcCtD
Pentazocine—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000911	0.00396	CbGpPWpGaD
Pentazocine—Tachycardia—Methylprednisolone—atopic dermatitis	0.00091	0.00122	CcSEcCtD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000908	0.00394	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000908	0.00394	CbGpPWpGaD
Pentazocine—OPRD1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.000905	0.00393	CbGpPWpGaD
Pentazocine—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000903	0.00122	CcSEcCtD
Pentazocine—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000901	0.00121	CcSEcCtD
Pentazocine—Insomnia—Hydrocortisone—atopic dermatitis	0.000897	0.00121	CcSEcCtD
Pentazocine—Hypertension—Betamethasone—atopic dermatitis	0.000897	0.00121	CcSEcCtD
Pentazocine—Hypertension—Dexamethasone—atopic dermatitis	0.000897	0.00121	CcSEcCtD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000893	0.00388	CbGpPWpGaD
Pentazocine—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000891	0.0012	CcSEcCtD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00089	0.00387	CbGpPWpGaD
Pentazocine—OPRM1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000881	0.00383	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CCL17—atopic dermatitis	0.000875	0.0038	CbGpPWpGaD
Pentazocine—Hypotension—Methylprednisolone—atopic dermatitis	0.000871	0.00117	CcSEcCtD
Pentazocine—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000863	0.00116	CcSEcCtD
Pentazocine—Vision blurred—Prednisone—atopic dermatitis	0.000853	0.00115	CcSEcCtD
Pentazocine—EBP—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	0.00085	0.00369	CbGpPWpGaD
Pentazocine—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000848	0.00114	CcSEcCtD
Pentazocine—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000848	0.00114	CcSEcCtD
Pentazocine—Insomnia—Triamcinolone—atopic dermatitis	0.000845	0.00114	CcSEcCtD
Pentazocine—Insomnia—Methylprednisolone—atopic dermatitis	0.000843	0.00113	CcSEcCtD
Pentazocine—Paraesthesia—Triamcinolone—atopic dermatitis	0.000839	0.00113	CcSEcCtD
Pentazocine—Feeling abnormal—Prednisolone—atopic dermatitis	0.000837	0.00113	CcSEcCtD
Pentazocine—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000837	0.00113	CcSEcCtD
Pentazocine—OPRK1—GPCR ligand binding—CCL11—atopic dermatitis	0.000834	0.00362	CbGpPWpGaD
Pentazocine—Shock—Dexamethasone—atopic dermatitis	0.000834	0.00112	CcSEcCtD
Pentazocine—Shock—Betamethasone—atopic dermatitis	0.000834	0.00112	CcSEcCtD
Pentazocine—Dyspnoea—Triamcinolone—atopic dermatitis	0.000833	0.00112	CcSEcCtD
Pentazocine—OPRD1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000832	0.00361	CbGpPWpGaD
Pentazocine—Agitation—Prednisone—atopic dermatitis	0.000831	0.00112	CcSEcCtD
Pentazocine—OPRM1—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.00083	0.0036	CbGpPWpGaD
Pentazocine—Tachycardia—Betamethasone—atopic dermatitis	0.000827	0.00111	CcSEcCtD
Pentazocine—Tachycardia—Dexamethasone—atopic dermatitis	0.000827	0.00111	CcSEcCtD
Pentazocine—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.00082	0.0011	CcSEcCtD
Pentazocine—Hyperhidrosis—Betamethasone—atopic dermatitis	0.00082	0.0011	CcSEcCtD
Pentazocine—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000818	0.0011	CcSEcCtD
Pentazocine—Vertigo—Prednisone—atopic dermatitis	0.000813	0.00109	CcSEcCtD
Pentazocine—Syncope—Prednisone—atopic dermatitis	0.000811	0.00109	CcSEcCtD
Pentazocine—OPRK1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.00081	0.00352	CbGpPWpGaD
Pentazocine—Anorexia—Betamethasone—atopic dermatitis	0.000808	0.00109	CcSEcCtD
Pentazocine—Anorexia—Dexamethasone—atopic dermatitis	0.000808	0.00109	CcSEcCtD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000796	0.00346	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000796	0.00346	CbGpPWpGaD
Pentazocine—Loss of consciousness—Prednisone—atopic dermatitis	0.000795	0.00107	CcSEcCtD
Pentazocine—OPRM1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000795	0.00345	CbGpPWpGaD
Pentazocine—OPRK1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.000794	0.00345	CbGpPWpGaD
Pentazocine—Hypotension—Betamethasone—atopic dermatitis	0.000792	0.00107	CcSEcCtD
Pentazocine—Hypotension—Dexamethasone—atopic dermatitis	0.000792	0.00107	CcSEcCtD
Pentazocine—Hypertension—Prednisone—atopic dermatitis	0.000781	0.00105	CcSEcCtD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000781	0.00339	CbGpPWpGaD
Pentazocine—OPRD1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.000779	0.00338	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—CCR3—atopic dermatitis	0.000776	0.00337	CbGpPWpGaD
Pentazocine—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00077	0.00334	CbGpPWpGaD
Pentazocine—Feeling abnormal—Triamcinolone—atopic dermatitis	0.00077	0.00104	CcSEcCtD
Pentazocine—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000768	0.00103	CcSEcCtD
Pentazocine—Insomnia—Betamethasone—atopic dermatitis	0.000767	0.00103	CcSEcCtD
Pentazocine—Insomnia—Dexamethasone—atopic dermatitis	0.000767	0.00103	CcSEcCtD
Pentazocine—Paraesthesia—Dexamethasone—atopic dermatitis	0.000761	0.00102	CcSEcCtD
Pentazocine—Paraesthesia—Betamethasone—atopic dermatitis	0.000761	0.00102	CcSEcCtD
Pentazocine—OPRD1—Signaling by GPCR—CCL22—atopic dermatitis	0.000758	0.00329	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000755	0.00328	CbGpPWpGaD
Pentazocine—Hypersensitivity—Prednisolone—atopic dermatitis	0.000749	0.00101	CcSEcCtD
Pentazocine—OPRD1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000744	0.00323	CbGpPWpGaD
Pentazocine—Anaphylactic shock—Prednisone—atopic dermatitis	0.000738	0.000993	CcSEcCtD
Pentazocine—Decreased appetite—Betamethasone—atopic dermatitis	0.000737	0.000991	CcSEcCtD
Pentazocine—Decreased appetite—Dexamethasone—atopic dermatitis	0.000737	0.000991	CcSEcCtD
Pentazocine—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000731	0.000984	CcSEcCtD
Pentazocine—OPRK1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.00073	0.00317	CbGpPWpGaD
Pentazocine—Shock—Prednisone—atopic dermatitis	0.000726	0.000977	CcSEcCtD
Pentazocine—Tachycardia—Prednisone—atopic dermatitis	0.000721	0.000969	CcSEcCtD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00072	0.00312	CbGpPWpGaD
Pentazocine—Hyperhidrosis—Prednisone—atopic dermatitis	0.000714	0.00096	CcSEcCtD
Pentazocine—Asthenia—Hydrocortisone—atopic dermatitis	0.000712	0.000958	CcSEcCtD
Pentazocine—OPRM1—GPCR ligand binding—CCL11—atopic dermatitis	0.000705	0.00306	CbGpPWpGaD
Pentazocine—OPRM1—TCR Signaling Pathway—CD4—atopic dermatitis	0.000704	0.00306	CbGpPWpGaD
Pentazocine—Anorexia—Prednisone—atopic dermatitis	0.000704	0.000947	CcSEcCtD
Pentazocine—Pruritus—Hydrocortisone—atopic dermatitis	0.000702	0.000944	CcSEcCtD
Pentazocine—OPRD1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000702	0.00305	CbGpPWpGaD
Pentazocine—Feeling abnormal—Betamethasone—atopic dermatitis	0.000699	0.00094	CcSEcCtD
Pentazocine—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000699	0.00094	CcSEcCtD
Pentazocine—OPRD1—GPCR ligand binding—NPS—atopic dermatitis	0.000691	0.003	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—TAC1—atopic dermatitis	0.000691	0.003	CbGpPWpGaD
Pentazocine—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000688	0.000926	CcSEcCtD
Pentazocine—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000687	0.000924	CcSEcCtD
Pentazocine—OPRM1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000684	0.00297	CbGpPWpGaD
Pentazocine—OPRK1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.000683	0.00297	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—CCR3—atopic dermatitis	0.00068	0.00295	CbGpPWpGaD
Pentazocine—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000679	0.000913	CcSEcCtD
Pentazocine—OPRD1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000678	0.00294	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CCL27—atopic dermatitis	0.000675	0.00293	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000673	0.00292	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000673	0.00292	CbGpPWpGaD
Pentazocine—Dizziness—Prednisolone—atopic dermatitis	0.000672	0.000904	CcSEcCtD
Pentazocine—OPRM1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.000671	0.00291	CbGpPWpGaD
Pentazocine—Asthenia—Triamcinolone—atopic dermatitis	0.00067	0.000902	CcSEcCtD
Pentazocine—Asthenia—Methylprednisolone—atopic dermatitis	0.000669	0.0009	CcSEcCtD
Pentazocine—Insomnia—Prednisone—atopic dermatitis	0.000668	0.000898	CcSEcCtD
Pentazocine—OPRK1—Signaling by GPCR—CCL22—atopic dermatitis	0.000664	0.00289	CbGpPWpGaD
Pentazocine—Paraesthesia—Prednisone—atopic dermatitis	0.000663	0.000892	CcSEcCtD
Pentazocine—Pruritus—Triamcinolone—atopic dermatitis	0.000661	0.000889	CcSEcCtD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00066	0.00286	CbGpPWpGaD
Pentazocine—Pruritus—Methylprednisolone—atopic dermatitis	0.00066	0.000887	CcSEcCtD
Pentazocine—Dizziness—Hydrocortisone—atopic dermatitis	0.000656	0.000883	CcSEcCtD
Pentazocine—OPRK1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000652	0.00283	CbGpPWpGaD
Pentazocine—OPRD1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000651	0.00283	CbGpPWpGaD
Pentazocine—OPRM1—TCR Signaling Pathway—IL1B—atopic dermatitis	0.00065	0.00282	CbGpPWpGaD
Pentazocine—Decreased appetite—Prednisone—atopic dermatitis	0.000642	0.000863	CcSEcCtD
Pentazocine—Dermatitis—Prednisolone—atopic dermatitis	0.00064	0.000861	CcSEcCtD
Pentazocine—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000638	0.000858	CcSEcCtD
Pentazocine—Headache—Prednisolone—atopic dermatitis	0.000636	0.000856	CcSEcCtD
Pentazocine—Constipation—Prednisone—atopic dermatitis	0.000631	0.000849	CcSEcCtD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000631	0.00274	CbGpPWpGaD
Pentazocine—Vomiting—Hydrocortisone—atopic dermatitis	0.000631	0.000849	CcSEcCtD
Pentazocine—Dermatitis—Hydrocortisone—atopic dermatitis	0.000625	0.000841	CcSEcCtD
Pentazocine—Headache—Hydrocortisone—atopic dermatitis	0.000622	0.000836	CcSEcCtD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000619	0.00269	CbGpPWpGaD
Pentazocine—Dizziness—Triamcinolone—atopic dermatitis	0.000618	0.000831	CcSEcCtD
Pentazocine—OPRM1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000617	0.00268	CbGpPWpGaD
Pentazocine—Dizziness—Methylprednisolone—atopic dermatitis	0.000616	0.000829	CcSEcCtD
Pentazocine—OPRK1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000615	0.00267	CbGpPWpGaD
Pentazocine—Feeling abnormal—Prednisone—atopic dermatitis	0.000608	0.000819	CcSEcCtD
Pentazocine—Asthenia—Dexamethasone—atopic dermatitis	0.000608	0.000818	CcSEcCtD
Pentazocine—Asthenia—Betamethasone—atopic dermatitis	0.000608	0.000818	CcSEcCtD
Pentazocine—OPRK1—GPCR ligand binding—TAC1—atopic dermatitis	0.000606	0.00263	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—NPS—atopic dermatitis	0.000606	0.00263	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CCL17—atopic dermatitis	0.000606	0.00263	CbGpPWpGaD
Pentazocine—Nausea—Prednisolone—atopic dermatitis	0.000604	0.000812	CcSEcCtD
Pentazocine—Pruritus—Dexamethasone—atopic dermatitis	0.0006	0.000807	CcSEcCtD
Pentazocine—Pruritus—Betamethasone—atopic dermatitis	0.0006	0.000807	CcSEcCtD
Pentazocine—OPRM1—TCR Signaling Pathway—MAPK8—atopic dermatitis	0.000596	0.00259	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000594	0.00258	CbGpPWpGaD
Pentazocine—Vomiting—Triamcinolone—atopic dermatitis	0.000594	0.000799	CcSEcCtD
Pentazocine—Vomiting—Methylprednisolone—atopic dermatitis	0.000593	0.000797	CcSEcCtD
Pentazocine—OPRK1—Signaling by GPCR—CCL27—atopic dermatitis	0.000592	0.00257	CbGpPWpGaD
Pentazocine—Nausea—Hydrocortisone—atopic dermatitis	0.000589	0.000793	CcSEcCtD
Pentazocine—Dermatitis—Triamcinolone—atopic dermatitis	0.000589	0.000792	CcSEcCtD
Pentazocine—Dermatitis—Methylprednisolone—atopic dermatitis	0.000587	0.00079	CcSEcCtD
Pentazocine—Headache—Triamcinolone—atopic dermatitis	0.000585	0.000787	CcSEcCtD
Pentazocine—Headache—Methylprednisolone—atopic dermatitis	0.000584	0.000786	CcSEcCtD
Pentazocine—Diarrhoea—Betamethasone—atopic dermatitis	0.00058	0.00078	CcSEcCtD
Pentazocine—Diarrhoea—Dexamethasone—atopic dermatitis	0.00058	0.00078	CcSEcCtD
Pentazocine—OPRM1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.000577	0.00251	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CCR3—atopic dermatitis	0.000575	0.0025	CbGpPWpGaD
Pentazocine—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000571	0.00248	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CCL22—atopic dermatitis	0.000562	0.00244	CbGpPWpGaD
Pentazocine—Dizziness—Betamethasone—atopic dermatitis	0.000561	0.000754	CcSEcCtD
Pentazocine—Dizziness—Dexamethasone—atopic dermatitis	0.000561	0.000754	CcSEcCtD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000558	0.00242	CbGpPWpGaD
Pentazocine—Nausea—Triamcinolone—atopic dermatitis	0.000555	0.000747	CcSEcCtD
Pentazocine—Nausea—Methylprednisolone—atopic dermatitis	0.000554	0.000745	CcSEcCtD
Pentazocine—OPRM1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000551	0.00239	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000548	0.00238	CbGpPWpGaD
Pentazocine—Hypersensitivity—Prednisone—atopic dermatitis	0.000544	0.000732	CcSEcCtD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000543	0.00236	CbGpPWpGaD
Pentazocine—Vomiting—Dexamethasone—atopic dermatitis	0.000539	0.000725	CcSEcCtD
Pentazocine—Vomiting—Betamethasone—atopic dermatitis	0.000539	0.000725	CcSEcCtD
Pentazocine—Dermatitis—Dexamethasone—atopic dermatitis	0.000534	0.000718	CcSEcCtD
Pentazocine—Dermatitis—Betamethasone—atopic dermatitis	0.000534	0.000718	CcSEcCtD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000533	0.00232	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CCL17—atopic dermatitis	0.000531	0.00231	CbGpPWpGaD
Pentazocine—Headache—Dexamethasone—atopic dermatitis	0.000531	0.000715	CcSEcCtD
Pentazocine—Headache—Betamethasone—atopic dermatitis	0.000531	0.000715	CcSEcCtD
Pentazocine—Asthenia—Prednisone—atopic dermatitis	0.00053	0.000713	CcSEcCtD
Pentazocine—Pruritus—Prednisone—atopic dermatitis	0.000522	0.000703	CcSEcCtD
Pentazocine—OPRM1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.00052	0.00226	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—TAC1—atopic dermatitis	0.000512	0.00222	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—NPS—atopic dermatitis	0.000512	0.00222	CbGpPWpGaD
Pentazocine—Diarrhoea—Prednisone—atopic dermatitis	0.000505	0.00068	CcSEcCtD
Pentazocine—Nausea—Dexamethasone—atopic dermatitis	0.000504	0.000677	CcSEcCtD
Pentazocine—Nausea—Betamethasone—atopic dermatitis	0.000504	0.000677	CcSEcCtD
Pentazocine—OPRD1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000503	0.00218	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000502	0.00218	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CCL27—atopic dermatitis	0.000501	0.00217	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000489	0.00212	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CCL11—atopic dermatitis	0.000488	0.00212	CbGpPWpGaD
Pentazocine—Dizziness—Prednisone—atopic dermatitis	0.000488	0.000657	CcSEcCtD
Pentazocine—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000483	0.0021	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FCER2—atopic dermatitis	0.000481	0.00209	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000481	0.00209	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—CCL5—atopic dermatitis	0.000472	0.00205	CbGpPWpGaD
Pentazocine—Vomiting—Prednisone—atopic dermatitis	0.000469	0.000632	CcSEcCtD
Pentazocine—Dermatitis—Prednisone—atopic dermatitis	0.000465	0.000626	CcSEcCtD
Pentazocine—Headache—Prednisone—atopic dermatitis	0.000463	0.000622	CcSEcCtD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000459	0.00199	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CCL17—atopic dermatitis	0.000449	0.00195	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCL22—atopic dermatitis	0.000448	0.00194	CbGpPWpGaD
Pentazocine—OPRK1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000441	0.00192	CbGpPWpGaD
Pentazocine—Nausea—Prednisone—atopic dermatitis	0.000439	0.00059	CcSEcCtD
Pentazocine—OPRD1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000438	0.0019	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CCL11—atopic dermatitis	0.000428	0.00186	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—CCR5—atopic dermatitis	0.000425	0.00185	CbGpPWpGaD
Pentazocine—OPRD1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000424	0.00184	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FCER2—atopic dermatitis	0.000422	0.00183	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—CCL5—atopic dermatitis	0.000414	0.0018	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000414	0.0018	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000406	0.00176	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCL27—atopic dermatitis	0.000399	0.00173	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CCR3—atopic dermatitis	0.000398	0.00173	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCL22—atopic dermatitis	0.000392	0.0017	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—NPS—atopic dermatitis	0.000391	0.0017	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000391	0.0017	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000384	0.00167	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000383	0.00166	CbGpPWpGaD
Pentazocine—OPRM1—TCR Signaling Pathway—IL6—atopic dermatitis	0.000381	0.00165	CbGpPWpGaD
Pentazocine—EBP—Metabolism—PPARA—atopic dermatitis	0.000378	0.00164	CbGpPWpGaD
Pentazocine—OPRM1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000373	0.00162	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—CCR5—atopic dermatitis	0.000373	0.00162	CbGpPWpGaD
Pentazocine—OPRK1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000372	0.00162	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—IL5—atopic dermatitis	0.000363	0.00158	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CCL11—atopic dermatitis	0.000362	0.00157	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCL17—atopic dermatitis	0.000358	0.00155	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FCER2—atopic dermatitis	0.000357	0.00155	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—TAC1—atopic dermatitis	0.000355	0.00154	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—NPS—atopic dermatitis	0.000355	0.00154	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCL27—atopic dermatitis	0.00035	0.00152	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CCL5—atopic dermatitis	0.00035	0.00152	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CCR3—atopic dermatitis	0.000349	0.00152	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000348	0.00151	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—NPS—atopic dermatitis	0.000343	0.00149	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000343	0.00149	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000337	0.00147	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000336	0.00146	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCL22—atopic dermatitis	0.000332	0.00144	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL5—atopic dermatitis	0.00033	0.00143	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000325	0.00141	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—KIF3A—atopic dermatitis	0.000319	0.00138	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—IL5—atopic dermatitis	0.000318	0.00138	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CCR5—atopic dermatitis	0.000315	0.00137	CbGpPWpGaD
Pentazocine—OPRM1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000314	0.00137	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCL17—atopic dermatitis	0.000314	0.00136	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—TAC1—atopic dermatitis	0.000311	0.00135	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—NPS—atopic dermatitis	0.000311	0.00135	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.00031	0.00134	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000305	0.00132	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000296	0.00128	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCL27—atopic dermatitis	0.000296	0.00128	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CCR3—atopic dermatitis	0.000295	0.00128	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—NPS—atopic dermatitis	0.00029	0.00126	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—TAC1—atopic dermatitis	0.00029	0.00126	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL5—atopic dermatitis	0.000289	0.00126	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CMA1—atopic dermatitis	0.000288	0.00125	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCL11—atopic dermatitis	0.000288	0.00125	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000284	0.00123	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000281	0.00122	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—KIF3A—atopic dermatitis	0.00028	0.00121	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000272	0.00118	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—STAT6—atopic dermatitis	0.000271	0.00118	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—IL5—atopic dermatitis	0.000269	0.00117	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000267	0.00116	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCL17—atopic dermatitis	0.000265	0.00115	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—NPS—atopic dermatitis	0.000263	0.00114	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—TAC1—atopic dermatitis	0.000263	0.00114	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000258	0.00112	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000257	0.00112	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CMA1—atopic dermatitis	0.000253	0.0011	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCL11—atopic dermatitis	0.000253	0.0011	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.00025	0.00109	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000247	0.00107	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL5—atopic dermatitis	0.000244	0.00106	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CCL5—atopic dermatitis	0.000242	0.00105	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CCR5—atopic dermatitis	0.00024	0.00104	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—STAT6—atopic dermatitis	0.000238	0.00103	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—KIF3A—atopic dermatitis	0.000236	0.00103	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCR3—atopic dermatitis	0.000235	0.00102	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000234	0.00102	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.00023	0.000997	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000225	0.000978	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CCR5—atopic dermatitis	0.000218	0.000947	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CMA1—atopic dermatitis	0.000214	0.000928	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCL11—atopic dermatitis	0.000214	0.000928	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CCL5—atopic dermatitis	0.000212	0.000922	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CCR5—atopic dermatitis	0.000211	0.000914	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NPS—atopic dermatitis	0.00021	0.00091	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TAC1—atopic dermatitis	0.00021	0.00091	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000208	0.000905	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCR3—atopic dermatitis	0.000206	0.000895	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CXCR3—atopic dermatitis	0.000206	0.000892	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—STAT6—atopic dermatitis	0.000201	0.000873	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000198	0.000858	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL5—atopic dermatitis	0.000195	0.000846	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CCR5—atopic dermatitis	0.000191	0.00083	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CXCL8—atopic dermatitis	0.00019	0.000827	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NPS—atopic dermatitis	0.000184	0.000798	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TAC1—atopic dermatitis	0.000184	0.000798	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CXCR3—atopic dermatitis	0.00018	0.000783	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CCL5—atopic dermatitis	0.000179	0.000779	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CCR5—atopic dermatitis	0.000178	0.000773	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCR3—atopic dermatitis	0.000174	0.000757	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL5—atopic dermatitis	0.000171	0.000742	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CXCL10—atopic dermatitis	0.000166	0.000721	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CCR5—atopic dermatitis	0.000162	0.000702	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NPS—atopic dermatitis	0.000155	0.000674	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TAC1—atopic dermatitis	0.000155	0.000674	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CXCR3—atopic dermatitis	0.000152	0.000661	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CXCL10—atopic dermatitis	0.000146	0.000633	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000145	0.000631	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL5—atopic dermatitis	0.000144	0.000627	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCL5—atopic dermatitis	0.000143	0.000621	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—IL2—atopic dermatitis	0.000139	0.000603	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NGF—atopic dermatitis	0.000132	0.000575	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CXCL8—atopic dermatitis	0.000132	0.000573	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCR5—atopic dermatitis	0.000129	0.000559	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000127	0.000553	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL2—atopic dermatitis	0.000126	0.000547	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCL5—atopic dermatitis	0.000125	0.000545	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CXCL10—atopic dermatitis	0.000123	0.000535	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—IL2—atopic dermatitis	0.000122	0.000528	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NGF—atopic dermatitis	0.000116	0.000504	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CXCL8—atopic dermatitis	0.000116	0.000502	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCR5—atopic dermatitis	0.000113	0.000491	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL2—atopic dermatitis	0.00011	0.00048	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NFKBIA—atopic dermatitis	0.000109	0.000474	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000108	0.000467	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCL5—atopic dermatitis	0.000106	0.00046	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—IL2—atopic dermatitis	0.000103	0.000447	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NGF—atopic dermatitis	9.81e-05	0.000426	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CXCL8—atopic dermatitis	9.77e-05	0.000424	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NFKBIA—atopic dermatitis	9.58e-05	0.000416	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCR5—atopic dermatitis	9.55e-05	0.000415	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL2—atopic dermatitis	9.34e-05	0.000406	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NFKBIA—atopic dermatitis	8.09e-05	0.000351	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CXCL8—atopic dermatitis	7.79e-05	0.000338	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL2—atopic dermatitis	7.44e-05	0.000323	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL6—atopic dermatitis	7.41e-05	0.000322	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MAPK8—atopic dermatitis	6.85e-05	0.000298	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CXCL8—atopic dermatitis	6.83e-05	0.000297	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL2—atopic dermatitis	6.53e-05	0.000283	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL6—atopic dermatitis	6.49e-05	0.000282	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MAPK8—atopic dermatitis	6.01e-05	0.000261	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CXCL8—atopic dermatitis	5.77e-05	0.000251	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL2—atopic dermatitis	5.52e-05	0.00024	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL6—atopic dermatitis	5.49e-05	0.000238	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MAPK8—atopic dermatitis	5.08e-05	0.00022	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL6—atopic dermatitis	4.38e-05	0.00019	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL6—atopic dermatitis	3.84e-05	0.000167	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL6—atopic dermatitis	3.24e-05	0.000141	CbGpPWpGaD
